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CHAPTER ,I
INTRODUCTION
Inadequate meat tenderness is a major problem for the beef industry.
The 1995 National Beef Quality Audit ranked inadequate tenderness as the
second most important beef quality problem (Smith et aI., 1995). The annual
economic loss associated with beef toughness equals $7.64 per animal or
$217.0 million to the beef industry (Smith et aI., 1995). In order to compete with
other food protein sources, the beef ilndustry must provide the consumer with a
consistently high quality, palatable product.
Postmortem tenderization of meat is attributed largely to the calcium
dependent proteolytic enzymes (COP), Il- and m- calpain (Koohmaraie et aI.,
1988a), and the endogenous calpain inhibitor, calpastatin (Koohmaraie et aI.,
1988b). Intracellular calcium concentrations usually are not high enough during
normal postmortem aging to activate m-calpain; therefore, most postmortem
tenderization is via ll-ca1pain (Vidalenc et aI., 1983; Koohmaraie et aI., 1987).
Koohmaraie et aL (1988a, 1990), Koohmaraie and Shackelford (1991), Morgan
et al. (1991 ),. and Wh,eeler et al. (1992) have shown that injecting meat with
calcium chloride increases tenderness through activation of the calpain
proteolytic system. Wheeler et a!. (1992) concluded that exogenous calcium
applied to prerigof muscles activates both Il- and m- calpain, accelerates
postmortem aging, and enhances meat tenderness.
Early studies of preventing parturient paresis in lactating dairy cows
showed that orally administered vitamin 0 at 5 million IU daily for two weeks
prepartum increased serum calcium 2.1 mg/dl (Hibbs et al., 1951". Hibbs and
Pounden (1955) observed that oral supplementation of 5, 10,20 and 30 million
IU of vitamin 0 for 3 to 8 d prepartum increased serum calcium by 1.9, 1.0, 1,9
and 2.3 mg/dl, respectively. Single injections of 1a.-Hydroxyvitamin D3 (500 or
700 Jlg) alone or in combination with 25-hydroxyvitamin 0 3 (4 mg) will increase
serum calcium concentrations by 1.8 to 2.4 mg/dl at 3 to 8 days post injection
(Bar et aI., 1985, 1988; Sachs et aI., 1987; Hodnett et aI., 1992). Therefore, we
tested the impact of supplemental dietary vitamin 0 3 on ionized blood calcium
ooncentration and tenderness of aged longissimus muscle steaks from beef
steers.
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CHAPTER II
REVIEW OF LITERATURE
Introduction
There are two major sources of dietary vitamin 0; cholecalciferol (vitamin
0 3 ), derived primarilly from animal sources, and ergocalciferol (vitamin O2),
produced by ultraviolet irradiation of the plant sterol ergosterol. Vitamin 0 is
known as the "sunshine vitamin" because cholecalciferol is synthesized by the
skin when exposed to ultraviolet light. Vitamin D has 8'ffects on intestinal
absorption, bone deposition and mobilization, and renal retention of calcium and
phosphorus. Vitamin 0 was recognized and used to treat rickets over 70 years
ago (Howland and Kramer, 1921).
Early studies comparing the biological activity of ergocalciferol and
cholecalciferol in mammals indicated that biological activity of the two was equal
~(Bethke et aI., 1946). More recently, cholecalciferol has been shown to have a
higher biolog.ical activity than ergocalciferol in New World monkeys (Hunt et aI.,
1967a,b, 1969), rats and pigs (Horst et aI., 1982), and horses (Harrington and
Page, 1983). Vitamin 0 3 has been known for many years to be substantially
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more active than vitamin O2 in birds (Chen and Bosmann, 1964) and also
appears to be two to three times more active in ruminants Sommerfeldt et aI.,
1983).
Absorption
Vitamin 0 like other fat soluble vitamins requires bile salt emulsification
for efficient absorption :into the lymphatic system. Orally administered vitamin 0
is absorbed in the small intestine '(Norman, 1980). Although absorption is most
active in the duodenum'(Schachter et aI., 1964), the greatest total amount is
absorbed in the ileum because of the long,er time that food spends there
r(Norman and Deluca, 1963). Norman and Deluca (1963) demonstrated that up
to 80% of orally administered radioactive vitamin D in oil was absorbed. I Norman
(1980) report.ed that 50% of oral'ly administered vitamin 0 passed through into
the lymph duct before entering the blood stream and then was transported to the
liver. Vitamin D injected as an alcoholic solution, is rapidly taken up by the liver.
After vitamin 0 3 is absorbed, large amounts accumulate in the liver so that the
blood does not contain high concentrationsv(Neville and Deluca, 1966).
~ Panchon and Deluca (1969) demonstrated that within 60 minutes, plasma
vitamin D is cleared from the blood into the liver. Vitamin D3 • transported in
b!lood bound to an a.-globulin (52,000 MW;Rikkers et aI., 1969), circulates in the
plasma at about 1-2 ng/ml (Deluca, 1979~, well below the concentration of its
major metabolite, 25-hydroxyvitamin 0 3.
Storage of vitamin 0
Ruminants do not store Ilarge amounts of vitamin D. In the rat, stored
vitamin D is primarily found in fat deposits and not in the liver as was once
believed (Rosenstreich et aI., 1971). Depletion of vitamin 0 in animals and man
lis a tedious process, likely to take years, primarily because it depends on
turnover of lipid deposits (Deluca, 1979). In contrast, vitamin D in plasma has a
very short lifetime, estimated at 22 h (Avioli et aI., 1967). 10.,25-
dihydroxyvitamin D3 has a plasma lifetime of only 2 to 4 h in humans (Gaynor et
al.,. 1989).
Activation of vitamin D
Vitamin 0 3 must be activated metabolically to be functional:
physiologically. Vitamin 0 3 taken up by the liver is converted to 25-
hydroxyvitamin D3 (25-0H-D3). 25-hydroxyvitamin D3 does not accumulate in the
liver (Deluca, 1979), but instead is the major circulating metabolite of Vitamin D3
in the blood. Likewi,se, 25-0H-D3 does not act directly at physiological
concentrations (Deluca and Schnoes, 1976) but must be transported to the
kidney were it undergoes 1a-hydroxylation to form 1a,25-dihydroxyvitamin 0 3
(1,25-(OHhD3 ); this is the form of vitamin 0 3 that is metabolically active; as
shown in Figure 1.
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Figure 1, Activation of vitamin 0 3
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25-hydroxylation
Identified chemically by Blunt et 'al. (1968), 25-0H-D 3 is hydroxylated from
vitamin 0 3 primarily in the liver at the 25 position of the carbon side chain
(Ponchon and DeLuca, 1969). Some 25-hydroxylation may occur in other
organs as Tucker et al. (1973) demonstrated that it also occurs in the kidney and
(,
intestine of chicks. Although Deluca (1974) detected no 25~hydroxylation in the
kidney of the chick, Bhattacharyya and Deluca (1974a) revealed that 25-
hydroxylation can occur in intestinal tissue from birds. Holick et al. (1976) found
no 25-hydroxylatiol1 in the intestine of rats. Olsen et aJ. (1976) concluded that
the liver is the major site of 25-hydroxylation.
The 25-hydroxylation system is located primarily in the microsomal
fraction of the liver (Bhattacharyya and Deluca, 1974b). A microsomal enzyme
with high affinity and low capacity hydroxylates the 25 carbon of the side chain
(McDowell, 1992). 25-hydroxylation requires NADPH, molecular oxygen,
magnesium ions, and the cytosolic fraction (Deluca, 1979). Cytochrome P450 is
not involved in this reaction (Bhattacharyya and Deluca, 1974a). The system is
stimulated by a protein from the supernatant fraction and requires reduced
pyridine nucleotide and molecular oxygen (Deluca, 1974).
1.25-hydroxylation
25-hydroxyvitamin 0 3 is transported to the kidney via the vitamin D3
transport binding protein transcaldferin that has a molecular weight of 52,000
(DeLuca, 1979), where it ils hydroxylated in the mitochondria at carbon 1 to yield
1,25-(OHh03' 1,25-hydroxylation is controlled directly by parathyroid hormone
(PTH); PTH increases the production of 1,25-(OHhD3 (Horiuchi et aI., 1976;
Booth etal., 1977). Parathyroid hormone's action is mediated by cyclic AMP
7
and plasma calcium; cAMP can increase 1,25-hydroxylation just as if PTH had
been provided (Suda et aL, 11977).
Mitochondria swollen with calcium ions use NADPH as their reducing
equivalent. NAOPH is the correct electron donor (Deluca, 1974); reduction is
independent of the electron transport chain and oxidative phosphorlation
(Deluca and Schnoes, 19761). The 1a.-hydroxylation of 25-0H-D3 to 1,25-
(OHhD3 involves the insertion of molecular oxygen using NAOPH, flavoprotein,
ferredoxin, and cytocrome P450 as the cofactors (Ghazar.ian et aI., 1974).
1a-hydroxylase is located in the proximal convoluted tubule cells of the
kidney cortex (Norman, 1974). Intact mitochondria use malate, succinate, or
other Krebs cycle substrates as the oxidizeable substrates to generate internally
reduced pyridine nucleotides (Deluca, 1974). These substrates along with
molecular oxygen generate reducing equivalents by reversal of the e~ectron
transport chain for the hydroxylation reaction (Deluca, 1974).
The kidney is the exclusive site of 1,25-(OHhD3 production in non-
pregnant mammals (Deluca, 1988). One exception to this is the placenta of
pregnant mammals; it has the ability to synthesize 1,25-(OHhD3 (Deluca, 1988).
125-dihydroxyvitamin D3
1,25-dihydroxyvitamin 0 3 clearly is the active form of vitamin 0 3 for
intestinal calcium (Boyle et al., 1972) and phosphate (Chen et aI., 1974)
absorption, and bone calcium mobilization (Holick et aI., 1972). Nephrectomized
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animals do not respond to vitamin 03or 25-0H-D3when given in physiological
amounts, but 1,.25-(OHhD3produces these responses either with or without the
kidney present (Deluca and Schnoe'S, 1976). Because vitamin 0 3and 25-0H-
0 3 are not metabolically active in physiological amounts, 1,25-(OH)03 must be
the active form of vitamin 03. Garabedian et al. (19748.) and Pechet and Hesse
(1974) demonstrated that vitamin 03and 25-0H-D3can produce a response by
binding to the 1,25-(OHh03 reoeptor in nephrectomized animals if doses are
large enough. large doses of 25-0H-D3 also cause mobilization of bone
calcium (Reynolds et al., 1973), calcium transport across the intestinal
membrane (Olson and Deluca, 1969), and production of calcium binding protein
(Corradino, 1973). However, none of these responses occur with doses of 25-
(OH)-03 at physiolog.icallevels.
Other metabol~ites of vitamin 03
Besides th,e production of 1,25-{OHhD3, the kidney converts 25-{OH)-D3
to 23(S),25-dihydroxyvitamin 03(23(S),25-(OHhD3 ), 24,25-dihydroxyvitamin D3
(24,25-(OHh03)., 25,26-dihydroxyvitamin 03(25,26-(OHhD3), 1,25,26-
trihydroxyvitamin 0 3 (1,25,26-(OHh03), and 1,24,25-trihydroxyvitamin 0 3
(1,24,25-(OHhD3). Hove et all. (19<83) conduded that 1,24,25-(OHh03 and
1,25,26-(OHhD3 were only one-tenth as potent as 1,25-(OHhD3 in causing
hypercalcemia. The role of these compounds is somewhat controversial and yet
to be determined.
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23-and 24- hydroxyl,ation of 25-0H-D3or 1,25-(OHhD3to 23{S),25-
(OHhD3, 24,25-(OHhD3or 1,24,25-(OH)3D3is a regulated process; when 1a-
hydroxylation of 1,25-(OHhD3 is suppressed, the 23- and 24- hydroxyl,ation
systems are elevated; see Figure 2. 23-hydroxylation produces a biologi:ca.lly
inactive form of vit.amin D (Deluca, 1988). 24-hydroxylase is a mitochondrial
enzyme (Knutson and Deluca, 1974), but the kidney is not the sale site of 24-
hydroxylation; the existence of 24-hydroxylase has been demonstrated in
intestinal tissue (Kumar et aI., 1978) and in cartilage tissue (Garabedian et aI.,
1977). Although more research is needed, 24-hydroxylation presumably is an
initial event in the inactivation of 1,25-(OHhD3(Deluca, 1979).
Vitamin 0 deficient animals show the same level of 1a.-hydroxylation
activity regardless of calcium or phosphorus status (Boyle et aI., 1971).
Supplementing a low calcium diet with vitamin 0 3 stimulates production of 1: ,25-
(OHhD3 ,whereas supplementation of a high calcium diet with vitamin 0 3turned
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off the production of 1,25-(OHhD3 and stimulated the production of 24,25-
{OHhD3. 1cx.-hydroxylase is not regulated by parathyroid hormone or calcium.
Administering 1,25(OHhD3 to vitamin 0 deficient rats will suppress 1a-
hydroxylase and stimulate 24-hydroxylase to produce 24,25-(OHhD3 (Deluca
and Schnoes,1976).
Vitamin D3 as a hormone
Vitamin D3 is consi,dered a hormone (Norman, 1979). This is because
1,25-(OHhD3 is produced in the kidney while it functions at other target organs
(intestine and bone), and its production jis regulated by serum inorganic
phosphorus and serum calcium (Deluca and Schnoes, 1976). The International
Union of Pure and Applied Chemistry (1960) defines cholecalcif,erol (vitamin D3 )
as a steroid hormone. Chemically, its name is 9,1 O-secocholesta-5,7, 10(19)-
trien-3p-ol.
Vi,tamin D regulation of calcium and phosphorus
Boyle et al. (1971) clearly demonstrated with rats that feeding low calcium
diets stimulated and high-calcium diets suppressed the production and
appearance of vitamin D3. How does the system differentiate between calcium
or phosphorus mobilization? Low serum calcium signals the secretion of PTH.
Parathyroid hormone activates renal mitochondria to convert 25-0H-D3 to 1,25-
{OHhD3 ;. both PTH and 1,25-(OHhD3 mobi'lize bone calcium and increase renal
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calcium reabsorption. low serum phosphorus signal the s,ecretion of 1: ,25-
(OHhD3 without increasing PTH; without PTH, then, bone calcium is not readily
mobilized and calcium is not completely reabsorbed from the kidney (Deluca
and Schnoes, 1976). In this manner, 1,25(OHhD3 can regulate both serum
calcium and phosphorus by having different effects at the kidney due to low or
high levels of PTH. Ribovich and Deluca (1975) demonstrated that rats
maintained on a phosphorus deprived diet and fed exogenous 1,25-(OHhD3 as
their only source of vitamin 0 3, had elevated intestinal calcium transport. Hence
these different signals can regulate the bOlle and: renal systems, but their
differential effects on intestinal transport needs more study.
Animals that are hypocalcemic synthesize 1,25-(OHhD3 and suppress 24-
23- hydroxylase, while animals that do not need calcium suppress 1,25-(OHhD3
production, except in the case where phosphorus is low which in turn can
stimulate 1a-hydroxylase production of 1,25-(OH) 203 (Deluca and Schnoes,
1976). When 1,25-(OHhD3 is suppressed, 24- and 23- hydroxylase production
are stimulated. Garabedi:an et al. (1972) demonstrated that removal of the
parathyroid gland in hypocalcemic animals eliminated 1,25-(OHhD3 production
and stimulated 24,25-(OHhD3 production. Administering PTH restored the
ability to produce 1,25-(OHhD3 and suppressed 24,25-(OHhD3 synthesis.
Fraser and Kodicek (1973) confirmed that PTH in chicks is the primary regulator
of 1,25-(OHhD3 synthesis in response to low blood calcium.
13
These hormones regulate calcium both independent and interdependently
via modifications of calcium and phosphorus absorption by the intestine,
mobilization from bone and reabsorption by the ki'dney.
Vitamin D3 increases blood calcium
Blood calcium homeostasis is regulated very closely; normal plasma
calcium concentrations continuously remains between 8 and 12 mg/dl in caUle.
Three factors r,egulate cailcium homeostasis; two peptide hormones, PTH and
calcitonin, and the steroid hormone 1,25-{OHhD3 . Calcitonin regulates
hypercalcemia by depressing calcium absorption from the gut, reducing bone
mineral resorption, and reducing renal calcium reabsorption (McDowell, 1992).
Parathyroid hormone stimulates 1,25-(OHhD3 production in response to low
blood calcium (Garabedian et aI., 1974b). Mobilization of calci,um from bones
and renal reabsorption of calcium requires both 1,25-(OHhD3 and PTH (Deluca,
1979; Sutton et al. ,1977; Kleeman et al., 1961). Increased intestinal absorption
of calcium responds only to 1,25-(OHhD3 and does not respond to PTH
(Garabedian et aI., 1974b). Parathyroid hormone increases intestinal calcium
absorption indirectly by stimul,ating 1,25-(OHhD3 production. Although the
intestine normally has an incredible ability to adapt to dietary calcium
(Nicolaysen, 1943), Ribovich and Deluca (1975) demonstrated that 1,25-
(OHhD3 eliminates the ability of the intestine to adjust to calcium absorption in
relation to dietary calcium levels.
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The effects of vitamin 0 3 on plasma calcium concentrations
For prevention of parturient paresis in lactatingJ dairy cows oraf
administration of vitamin D2 at 5 million IU daily for two weeks has been used;
this increased prepartum serum calcium by 2.1, mg/dl (Hibbs et aI., 19511). Hibbs
and Pounden (1955) observed that oral supplementation of 5, 10 1 20 and 30
million IU of vitamin D for 3 to 8 d prepartum increased serum calcium by 1.9,
1.0, 1.9, and 2.3 mg/dl, respectively.
Intramuscular injections of vitamin D3 have effects similar to oral
administration. Horst and Littledike (1979) demonstrated that four weekly
injections of 15 million IU of vitamin 0 3 increased blood calcium by
approximately 3.5 mg/dl. Elevated blood calcium levels began 8 to 10 d after the
first injection of vitamin 0 3 and continued to increase after each injection,
peaking 3 d after the fourth injection. 1,25-dihydroxyvitarni!n 0 3 levels continued
to incr,ease after each injection, but levels declined between injections,
demonstrating that 1,25-(OHhD3 has a short half life.
In studies of parturient paresis, 1a.-hydroxyvitamin 0 3 (1 a-OH-03 ) causes
even faster increases in serum calcium concentrations. 1a-hydroxyvitamin 0 3 is
hydroxylated rapidly to 1,25-(OHh03 by the Ever (Fukushima et aI., 1978). A
single 700 ~gl injection of 1a-OH-D3 increased blood calcium 1.8 mg/dl to 2.4
mg/dl by 4 to 8 d postinjection; blood calcium remained high for 14 days (Bar et
aI., 1985, 1988; Sachs et aI., 1987). 1a-hydroxyvitamin D3 concentrations
peaked at 24 to 48 h post injection but dropped to initial concentration 5 to 7 d
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postinj'ection. Baret al. (19'85) est.imated that the biological half life of 10.-
hydroxyvitamin 0 3 was 2.1 d
Hodnett et al. (1992) utilized 500 Ilg of 1o.-hydroxyvitamin 0 3 to quickly
increase pr!asma calcium; 4 mg of 25-0H-03administered every 5 d maintained
an increased plasma calcium. Plasma calcium was increased by 2 mg/dl at 5 to
7 d postinjection. Calcium and 1,25(OH)zD3 remained hrigh until parturition, 15 d
after the first injection.
The' active metabolite of vitamin 0 3also can increase blood calcium
concentration and may be beneficial because 1,25-(OHhD3 may have a direct
effect on the gut, increasing intestinal caldum absorption. Goff et al. (1989)
demonstrated that 1,25-(OHhD3 injected! daily for 7 d increased blood calcium by
1.9 mg/dl on d 3 and continued to elevate blood calcium 8 d after the last
injection, with a peak increase at approximately 2.8 mg/dl some 7 to 9 d after the
first injection.
Intramuscular injections of 1o.-OH-03 increased 1,25-(OH)z03
concentrations longer than equivalent amounts of 1,25-{OHh03 (Carstairs et aL,
1981; Hove et aL, 1981). Intramuscular injections of either 1o.-OH-D3 or 1,25-
(OHh03 resulted in 5 times greater blood 1,25-(OH)zD3 levels than orally
administered 1o.-OH-D3 or 1,25-(OHhD3, but the decline after peak
concentration occurred more slowly after oral administration than after i.m.
administration (Hove et al., 1983). Although blood 1,25-(OH)zD3 I,evels vary with
type of administration of 1,25-(OHhD3, degre,e of hypercalcemia was comparable
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with oral and i.m. admini;stration of 1,25-(OH)2D3; both types of administration
increased blood calcium by 20 to 30% above pretreatment levels for 5 d (Hove
et aL, 1983). This suggests that orally administered 1,25-(OHhD3 may have a
direct effect on the gut to increase intestinal calcium absorption. If 1,25-(OHhD3
is used to increase blood calcium, oral administration may be more
advantageous because although equivalent plasma calcium concentrations can
be achieved, the lower plasma 1,25-(OHhD3concentration could cause less
feedback inhibition of renal 1a.-hydroxylase enzyme by 1,25-(OHhD3circulating
in the blood. With cattle mean plasma calcium concentrations with 1a..-OH-D3
injected i.m. was similar to that of 1,25-(OHh03, but orally administered 1a..-OH-
0 3 only increased plasma calcium by 10% indicating that 1a.-O H-D3 may be
degraded in the rumen.
Another metabolite of vitamin 0 3, has recently been the subject of interest.
Goff et al. (1986) demonstrated that cattle when injected intramuscularly, 24,24-
difiluoro-1 ,25-dihydroxyvitamin 0 3 (24,24-Fr 1,25-(OHh03) was approximately
four times more active than equivalent dose of 1,25-(OHhD3 . Similar studies in
the rat (Okamoto et aI., 1983) and the chick (Corradino et aI., 1980) confirmed
that 24,24-F2-1,25-(OHb03 has a biological activity higher than 1,25-(OHhD3.
Intravenous administration of 2 million IU of vitamin D3 increased serum
calcium 0.9 mg/dl on d 2 and 3; intramuscular injecting the same dose of vitamin
0 3 resulted in a smaller, but more prolonged increase of serum calcium from d 2
to 25 (Boling and Evans, 1979).
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Mechanisms
Vitamin 0 increases plasma calcium concentration by stimulating
intestinal calcium absorption (Nicolays,en, 19'37), mobilizing calcium from
previously formed bone mineral (Carlsson, 1952), and increasing renal
reabsorption of calcium from the kidney (Sutton and Dirks, 1978).
Urinary hydroxyproline excretion has been used as an index of bone
r,eabsorption in cattle (Black and Capen, 1971). Goff et al. (1986) demonstrated
that glomerular filtration rate is reduced during hypercalcemia; hence, plasma
hydroxyproline levels may be a better index of bone resorption during periods of
hypercalcemia. Bone resorption of calcium probably only contributes slightly to
the increase calcium concentration seen after vitamin 0 3 supplementation
because plasma hydroxyproline concentrations are either reduced (Hove et aI.,
1983) or remain unchanged (Goff et al., 1986) during the hypercalcemic period.
Bar et al. (1.988) demonstrated that prepartum PTH levels did not increase in
cows injected with 1a-hydroxyvitamin D3; PTH and 1,25-{OHhD3 are both
needed to incr,ease bone resorption and' renal reabsorption of calcium, but PTH
is not needed for intestinal calcium absorption. Hove et al. (1984) and
Braithwaite (1980) concluded' that hypercalcemia caused by pharmacological
doses of vitamin D or its metabohtes probably is the result of stimulation of
transcellular calcium transport in the intestinal tract.
Intestinal calcium absorption
i8
Calcium absorption from the small intestine occurs via two independent
processes. The first is a saturable transcellular process that is regulated by
vitamin D and its product vitamin D-dependent calcium-binding protein (CaSP,
MW = 8800). Absorption takes pl.ace in the duodenum and upper jejunum
(Pansu et al. I 1983a). The second process is nonsaturable, it is concentration
dependent, and it moves calcium paracellulary along the entire length of the
small intestine (Behar and Kerstein, 1976; Pansu et aI., 1983a). The Nernst
eq~ation predicts net flux of calcium into extracellular fluid (Goff et aI., 1991),
when ionized calcium concentration over the epithelial cells exceeds 6mM. In
the rat, 16% of the luminal calcium concentration is transferred to the body fluids
per hour (Pansu etal., 1981, 1983a, 1983b).
When dietary calcium is low or calcium is in demand most intestinal
calcium absorption occurs via the transcellular active transport system. When
adequate dietary calcium is provided, most intestinal calcium absorption occurs
through the non-saturable concentration dependent process.
Transcellular intestinal calcium absorption
The saturab'le process of transcellular calcium movement involves three
steps. In the first step, calcium enters the eel via the brush border membranes
on the luminal side of the intestinal cell. In the second step, calcium diffuses
across the cell cytoplasm to the basal lateral side of the cell. In the third step,
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calcium is extruded :into the extracellular fluid at the basolatera~ pole of the cell.
These three steps must occur in dynamic equilibrium (Bronner, 1987).
Step 1
Calcium 'entry into the cell occurs rapidly without the expenditure of
metabolic energy because calcium concentration is 1000-fold greater in the gut
than in the interior of the cell. The capacity of calcium to enter the brush-border
membrane is not the rate limiting: step for transcellular calcium transport
(Bronner, 1987).
Slep 2
Feher (1983,1984) demonstrated that vitamin D-dependent calcium-
binding protein acts as a intracellular ferry to transfer calcium across the cell to
the basal later side. This is the rate limiting step in transcellular calcium
transport (Bronner, 1987). Calcium-binding protein increases the intracellular
calcium gradient between the brush border and the basolateral poles of the cell,
providing the driving force needed for calcium diffusion (Bronner, 1987). There
is a close Unear relationship between the rate (Bronner et al., 1986) and amount
of calcium transported (Roche et aI., 1986) to the intestinal content of CaSP.
1,25-dihydroxyvitamin D3 promotes the synthesis of intestinal CaBP (Hoffmann-
La Roche, 1994).
Step 3
Extrusion of calcium from the cell against a 1000-fold concentration
gradient requires metabolically driven Ca:Mg-ATPase-dependent pumps
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(Bronner, 1987). Calcium-binding protein does not stimulate the Ga:Mg-
ATPase-dependent pump to extrude calcium (Ghijs'el1 et aI., 1986); these
Ca:Mg-ATPase pumps normally operate at much less than their maximum
velocity but they are able to adequately handle the calcium flux across the cell
when CaBP is transporting calcium at its maximum rate (Bronner, 1987).
Although it does not stimulate calcium transport, 1,25-(OHhD3 increases Ca:Mg-
ATPase activity by 2 or 3 fold (Bronner et aI., 1986), although they still pump at
much less than maximum velocity.
Rasmussen et at (1982) postulated that 1,25-(OHhD3 can cause a
change in the fluidity of the plasma membrane of the intestinal target cell that
allows more calcium to enter, but that it did not alter the magnitude of CaSP.
This change in calcium permeability is independent of vitamin 0 induced CaSP
synthesis. Intracellular calcium and 1,25-(OHhD3 lev,els may playa role in the
posttranscriptional regulation of CaSP expression (Branner and Buckley, 1982).
Calcium intake greatly effects the route of calcium transport. An increase
in dietary calcium leads to down-regulation of the vitamin 0 dependent saturable
process (Pansu et aI., 1981). The amount of calcium moved by the nonsaturable
route will increase in direct proportion to calcium intake. Decr,easing dietary
calcium will have tlhe opposite effect.
Calcium dependent proteases
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Calcium depend,ent proteases (CDP) are major contributors to the
tenderization process during postmortem aging (Koohmaraieefal., 1,9'86, 1987,
1988a, 1988b). Calcium dependent proteases degrade myosin (lshiura et at,
1979), Z-disks (Dayton et aI., 1976a,b), troponin-T and desmin (Koohmaraie et
aI., 1986). Two distinct forms of COPs exist; Il- (COP-I) an.d m- (CDP-II) calpain.
Activation of ll-ca1pain requires 50 to 70 IJM calcium while activation of m-
calpain requires 1 to 5 mM calcium (Mellgre.n, 1980; Dayton et al. , 1981;
Szpacenko etal., 1981; Goll et al., 1983; Inomata et aI., 1985; Karlsson et aI.,
1985). Intracellular calcium concentratiofls usually are not high enough durin9
norma'l postmortem aging to activate m-calpain; therefore, most postmortem
tenderizati,on is via ll-ca1pain (Vidalenc et aI., 1983; Koohmaraie et al., 1987,
1988a). Koohmaraie st al. (1988a,b, 1990), Koohmaraie and Shackelford
(1991), Morgan et al. (1991), and Wheeler et al. (1991, 1992) have shown that
injecting meat with calcium chloride increases tenderness through activation of
the calpain proteolytic system. Wheeler et al. (1992) concluded that exogenous
calcium applied to prerigor muscles increased intracellular calcium
concentration, activating both 11- and m- calpain, accelerating postmortem aging,
and enhancing meat tenderness.
Vitamin 0 toxicity
The maximum tolerable level for vitamin D in the diet has not been
established. Factors such as chemical form (vitamin O2 or vitamin 0 3), potency
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of the metabo:lites and their biological half lives, animal species, dietary calcium
and phosphorus, route of a.dministration, stage of production, and length of
treatment all can influence the upper safe level of vitamin D.
Chemical form
Vitamin D3 is more potent than vitamin O2 in most species but the
difference in the degree of potency is species dependent. Cholecalciferol has a
higher biologica activity than ergocalciferol, in New World monkeys (Hunt et aL,
1967a,b, 1969), rats and pigs (Horst et aI., 1982), and horses (Harrington and
Page, 1983). Vitamin 0 3 is substantially more active than vitamin 02in birds
(Chen and Bosmann, 1964}, and two to thr,ee times more active in ruminants
(Sommerfeldt et aI., 1983). NRC (1987) indicates that vitamin D3 is 10 to 20
times more toxic than vitamin 0 3 in ruminants when given in excessive amounts.
Potency
Various metabolites differ in potency. The relative potency of vitamin 0
and its metabolites are: 24,24-F2-1,25-(OHhD3 > 1,25-(OHhD3 = 1a-OH-03 > 25-
OH-03 > Vitamin D3 > 24,25-(OHhD3 > 1,24,25-(OHhD3 = 1,25,26-(OHh03.
Biological half life of each metabolite also affects the degree of toxicity: 25-0H-
0 3 > vitamin D3 > 1,25-(0Hh1J3. > 1a-OH-D3 (NRC, 1987).
Mineral Status
Availability of dietary calcium for absorption can increase the degree of
vitamin D toxicosis when pharmacological doses of vlitamin 0 are given (Hines et
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air., 1985). Feeding: a low phosphorus diet increases calcium absorption both
wi,th or without large doses of vitamin D.
Route ofAdministration
The potential for vitamin D toxicity is influenced by route of administration:
intravenous> intramuscular> oral. This is not necessarily true for 1,25-(OHhD3
or 25-0H-D3 because 1,25-(OHhD3 does not need to !be absorbed but can have
a local effect on the gut increasing:'calcium absorption; 25-0H-D3 when given in
large enough doses can have the same local effect as 1,25-(OH)2D3 (Have et aI.,
1983). Rumen microbes can partially metabolize and deactivate vitamin 0 in the
rumen (Napoli et aI., 1983).
Stage of Production
Pregnant cows are much more likely to develop vitamin 0 toxicity than dry
cows (Littledike and Horst, 1980). Toxic effects of vitamin 0 are greater if
vitamin 0 3 treatment precedes parturition by several weeks (Littledike and Horst,
1982). 1a,25-dihydroxyvitamin D3 receptors increase during pregnancy and
lactation in the cow (Goff et aL, 1991). The number of 1,25-(OHhD3 receptors
decline with age in both the rat and cow (Horst et at, 1990).
Duration of Suppiementaion
Duration of vitamin 0 treatment also can affect the onset of vitamin D
toxicosis. Most species of animals appear to be able to tolerate 10 times (2,200
IU per kg of body weight for ruminants) their dietary vitamin 0 requirements for
long periods of treatment (greater than 60 d); for short periods of treatment (less
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than 60 d) most species are able to tolerate up to 100 times (22,000 'IU per kg of
body weight for ruminants) dietary requirements (NRC, 1987).
Mechanisms
Increasing blood calcium levels beyond its normal boundaries due to
excessive vitamin D supplementation can produce a variety of effects
(McDowell, 1992). The kidney can handle a 10 to 20% increase in serum
calcium without effecting GFR (NRC, 1987) but further increases in serum
calcium will cause GFR to decrease because of nephrolithiasis caused by
hypercalciuria. This reduction in renal function causes a loss of control of
calcium homeostasis resulting in hyperca!lcemia which in turn causes extensive
calcification of soft tissue (NRC, 1987).
Signs of toxicity
The first sign of vitamin D toxicity in cattle is inappetence; severe
anorexia lasts several weeks and may cause death (littledi,ke and Horst, 1982).
Other signs of vitamin D toxicity are reduced rumination, depression, pasty
discharge around the eyes, rough dry hair coat, delayed shedding, reduced milk
production, stiffness and inflammation of muscles and joints, excessive water
intake, air bubbles under the skin around injechon sites, crepitation of the skin in
the injection area, thinning of bones, decreased blood Mg, premature ventricular
systoles, and: bradycardia (Littledike and Horst, 1982; NRC, 1987; McDowell,
1992; Hoffmann-La Roche, 1994).
Result of toxicity
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Wiidespread mineralization of the kidney, cardiovascular system,
respiratory tract and the salivary glands is evident during postmortem
examination of vitamin D intoxicated animals; lesions in these areas usually are
a result of mineralization. The kidney usually is the first place to find soft tissue
mineralization, with the collecting tubules of the medulla being the major site of
mineralization with less mineralization of tine cortex (Capen et al., 1966; Simasen
at aI., 1978). Cardiovascular lesions caused by extensive, mineralization are
lo~at,ed primarily in the aorta, aorta valves, aortic arch, arteriole wall, stomach
mucosa, large arterial bifurcations, and small vessels {NRC, 1987). Cafcification
of the smalt bronchi, alveolar ducts, alveolar septa, and bronchial cartila.ge and
submucosa (Kent at aI., 1958; Chineme, 1976) also is evident during
postmortem examination. Calcification of the submaxillary and parotid salivary
glands are the next most frequently seen lesions that result from vitamin 0
toxicity (Kent et aI., 1958).
CHAPTER III
MATERIALS AND METHODS
In Exp. 1, 118 steers (528 kg mean live weight), consisting of 20 Angus-
Hereford crossbred steers in Trial 1 and 98 Saler or Charolais-s.ired steers with
Brangus dams in Trial 2, were supplemented with either 0 or 5 million IU of
vitamin 0 3 per day for 5 d immediately prior to slaughter. Steers in Trial 1 were
assigned randomly to 8 pens, with either 2 or 3 steers per pen. Steers in Trial 2
were divided into groups based on breed of sire (Charolais or Saler) and weight
class (heavy, medium and light). Steers in Trial 2 were assigned randomly to 20
pens with 4 or 5 steers per pen. In Exp. 2, 44 crossbred ste-ers (570 kg mean
weight) slaughtered on two different dates, designated as trial 3 and 4, were
supplemented with either 0 or 7.5 million IU of vitamin 0 3 per day for 10 d
immediate'ly prior to slaughter. In Trial 3,. 20 steers were fed individually; in Trial
,
4, 24 steers were f,ed in 4 pens with 6 ste-ers per pen. To ensure that all of the
vitamin 0 3 included in the diet was consumed, steers in both experiment 1 and 2
were limit fed their high concentrate diet (1.5 % of their body weight daily) while
vitamin 0 3 was supplemented. All steers were slaughtered at commercial
packing plants. Following a 48 hour postmortem chill (2°C), yield and quality
grade of each carcass was determined by a USOA grader and a rib section was
removed from the left side of each carcass. Longissimus muscle steaks (2.5 cm
thick) were prepared, vacuum packaged, aged at 2°C for either 7, 14 or 21 d
(except for Trial 1 when only 1 steak was prepared and aged 7 d) and then
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frozen at -30°C. Steaks later were thawed for 24 hours at 2°C and broiled on a
impingement oven to an internal temperature of 70°C. After cool,jng to 20°C,
eight 1.3 em diameter core samples were obtained from each steak; shear force
values were measured using aWarner-Bratzler attachment to an Instron
Universal Testing Machine. The maximum shear force value determined for
each of the eight core samples, was averaged and used as a single
measurement.
Plasma from blood samples obtained during exsagination in Trial 1 were
analyzed for calcium, magnesium, triglyceride, glucose, chlorine, phosphorus,
sodium and potassium using a Roche Cobas Mira (Roche Diagnostic Systems,
Inc., New Jersey).
In Exp. 3, 20 crossbred steers (550 kg mean weight) were assigned
randomly to one of four treatments. Steers were individually fed 1.5 % of their
body weight daily and supplemented with either 0, 2.5, 5.0 or 7.5 million IU of
vitamin D3 per day for 10 d with 5 steers per dose level. Blood samples were
obtained daily during this supplementation period and 5 d thereafter. Blood
plasma samples were analyzed for ionized calcium using a Orion calcium ion
selective electrode (Orion Research Incorporated, Boston, MA). Ionized blood
calcium concentrations for treatment groups were calculated.
For statistical analysis, samples from Exp. 1 were considered to be
blocked by Trial (1 and 2) and for Trial 2 by breed of sire and weight class.
Levene's test was performed to test for heterogeneity of variances among the 12
group by treatment combinations. Variance was not heterogeneous according to
that test. Shear force and carcass data were analyzed using the general linear
mode,1 procedure of SAS (1985) using pen(rep*trt) as the error term. For Exp. 2,
Trial 3 and Trial 4 were considered as two blocks based on feeding system
(individual vs pen fed) and slaughter date. The mixed model procedure of SAS
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(1985) was used to analyze shear force and carcass data for Exp. 2. In Exp. 3,
contrasts were used to determine effects of providing vitamin 0 3 and whether the
response was linearly related to dosage.
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CHAPTER IV
RESULTS AND DISCUSSION
In Trial 1 (Table 1), vitamin D3 supplementation resulted in 26.6% lower
(P<.001) blood plasma magnesium concentration, while blood plasma calcium
was 12.6% greater (P<.03).
Least square means for carcass characteristics for Exp. 1 are reported in
Table 2. Carcass weight (P<.08) and ribeye area (P<.08) both tended to be
greater for control steers, presumably due to chance. Least square means for
shear force values for Exp. 1 are reported in Table 3. WBS values were 6.6%
lower (P<.01) (more tender) and the number of tough steaks was 21.8% lower
(to P<.01 ) for steers supplemented vi,tamin D3 at 7 d postmortem aging.
Least square means for carcass characteristics for Exp. 2 are reported in
Table 4. Marbling score (P<.06} and final yield grade (P<.09) both tended to be
greater for steers suppl.,emented with vitamin D3 • presumably due to chance. In
Exp. 2 (Table 5), vitamin 0 3 supplementation resulted in 18.0% lower (P<.02)
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WBS values at 7d postmortem aging and tended to reduce the number of tough
st,eaks by 23.3% (P<.09), and by 22.5% (P<.07) a114 and 21 d of postmortem
aging.
In Exp. 3 (Figure 1), mean concentrations of ionized blood calcium are
plotted as a percentage of those of control steers. Supplemental vitamin 0 3
increased ionized blood calcium concentrations (P<.01 P<.04) on d 6 through 13
and d 15, and tended to increase concentrations on d 5 (P<.07) and d 14
(P<.09). Response to dosage of vitamin 0 3 was linear on d 6 through 13 and 15
(P<.01 to P<.03) and tended to be linear on d 5 (P<.07).
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Table 1. Least squares means for blood plasma samples for steers supplemented with either 0 or 5 million IU of vitamin
0 3 for 5 days prior to slaughter (Trial 1)
- ....
Vitamin 0 3 • IU/d
Item 0 5 * 106 SE Probability level (P<)
Steers, n 10 10
Ca, mg/dl 9.23 10.39 0.29 .03
Mg, meqll 1.99 1.46 0.06 .001
Triglyceride, mg/dl 22.5 26.9 2.20 .21
<..J Glucose, mg/dl 153.6 200.2 38.01 .42
UJ
Cl,mM 103.6 104.0 1.08 .79
P, mg/dl 6.66 6.36 0.15 .20
Na, mM 149.2 148.0 1.51 .58
K,mM 7.22 6.77 __ ~~__0.44 _ .50
Table 2. Least squares means for carcass traits for steers supplemented with either 0 or 5 million IU of vitamin 0 3 per
day for q d~ys prior tc:>_sla_ughter (Trials 1 and 2)
Item
Vitamin 0 3 • IU/d
o 5 • 106 SE_ Probapilit'llevel (P<)------------=~------=----'-"'---
Steers, n 59 59
Carcass weight, kg 336.2 326.4 3.53 .08
Marbling score a 300.4 294.5 9.00 .70
Preliminary Yield Grade 2.85 2.80 0.03 .35
.....
Final Yield Grade 2.40 2.37 0.08 .91
~
Ribeye area, cm2 86.2 84.1 0.80 .08
Internal (KPH) fat, % 1.96 1.87 0.06 .39
Skeletal Maturity b 148.8 145.9 2.44 .43
Lean Maturit'i C 136.1 139.9 2.43 .30
a Marbling score: 200 to 299 ="traces" (U.S. Standard); 300 to 399 ="slight" (U.S.
Select).
b Skeletal maturity: 100 to 199 = A maturity: approximately 9 to 30 months chronological
age at slaughter.
C Lean maturity: 100 to 199 =light cherry red, fine in texture.
Probability level (P<)SEItem
Table 3. Least squares means for Warner~Bratzlershear force values for steers supplemented with either 0 or 5 million
IU of vitamin O~ per day for 5 days grior to slaughter (Trials 1 and 2)
Vitamin 0 3• IU/d
o 5 * 106
59 59
w
VI
Steers, n
Shear force, kg
Aged 7 day
Aged 14 day
Aged 21 day
Steaks with shear force values> 4.5 kg, %
4.70
4.03
3.58
4.39
3.87
3.60
0.08
0.09
0.11
.01
.25
.90
Aged 7 day 56.0 34.2
Aged 14 day 20.0 17.0
Aged 21 day 6.0 8.0
5.53
7.22
4.75
.01
.78
.77
Table 4. Least squares means for carcass traits for steers supplemented with either 0 or 7.5 million IU of vitamin 0 3 per
day for 10 prior to slaughter (Trials 3 and 4L
Vitamin D3 ! IU/d
Item 0 7.5 tOt 106 SE Probability level !P<)
Steers, n 22 22
Carcass weight, kg 358.5 368.4 7.56 .38
Marbling score a 384.3 434.0 18.0 .06
Preliminary Yield Grade 2.81 3.00 0.10 .15
w
Final Yield Grade 2.16 2.63 0.19 .09
C\
Ribeye area, cm2 92.5 90.0 2.45 .50
Internal (KPH) fat, % 1.99 2.30 0.17 .20
Skeletal Maturity b 130.0 124.7 3.95 .35
Lean Maturity C
-
185.3 177.7 10.92 .62
a Marbling score: 300 to 399 :: "slight" (U.S. Select); 400 to 499 :: "small" (U.S. Choice).
b Skeletal maturity: 100 to 199 :: A maturity: approximately 9 to 30 months chronological
age at slaughter.
C Lean maturity: 100 to 199 :: light cherry red, fine in texture.
Table 5. Least squares means for WarnerpBratzler shear force values for steers supplemented with either 0 or 7.5
million IU of vitamin 0 3 per day for 10 prior to slaughter (Trials 3 and 4)
Vitamin 0 3, IU/d
Item 0 7.51<106 SE Probability level (P<)
Steers, n 22 22
Shear force, kg
Aged 7 day 5.13 4.21 0.28 .02
Aged 14 day 4.40 3.81 0.25 .13
w
-I
Aged 21 day 4.04 3.44 0.24 .13
Steaks with shear force values> 4.5 kg, %
Aged 7 day 55.8 39.2 9.59 .23
Aged 14 day 47.5 24.2 9.37 .09
AQed 21 day 32.5 10.0 8.46 .07
CHAPTER V
SUMMARY AND CONCLUSIONS
Dietary supplementation with vitamin 03 for 5 or 10 d prior to slaughter
increased tenderness of longissimus steaks at 7 d postmortem aging.
Supplementation with vitamin 03 for 5 d also reduced the percentage of tough
steaks at 7 day of postmortem aging whereas supplementation with 7.5 million
IU for 10 d prior to slaughter tended to decrease the percentage of tough steaks
at the longer aging periods. Optimum dosage levels and times for vitamin 0 3 to
reduce shear force of the longissimus and other muscle groups remain to be
pinpointed.
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